approval
saveLUNSUMIO (MOSUNETUZUMAB-AXGB) — FDA approval
community read0 votes
Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INJECTION
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 2
same company · ±60 days · 6
- approvalobinutuzumab: GAZYVA (OBINUTUZUMAB) — FDA approvalDec 17, 2025
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalDec 10, 2025
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalDec 10, 2025
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalNov 24, 2025
- approval(atezolizumab + hyaluronidase (human recombinant)): TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approvalNov 17, 2025
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalNov 17, 2025
comments(0)
5-min edit window · permanent after that